Akorn, Inc. (NASDAQ: AKRX), a niche generic pharmaceutical company, today reported financial results for the first quarter ended March 31, 2014.
First Quarter 2014 Key Highlights and Accomplishments
•Achieved record first quarter consolidated revenue of $90.6 million, an increase of 23% over last year’s first quarter.
Help employers find you! Check out all the jobs and post your resume.
